AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2

Modify Date: 2025-08-24 20:34:24

AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2 structure	Common Name	AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2
	CAS Number	121822-32-0	Molecular Weight	846.92700
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₃₈H₅₈N₁₀O₁₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of AC-SER-GLN-ASN-TYR-PRO-VAL-VAL-NH2

Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 is a substrato peptídico of HIV-1 protease.Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 acts as the variable substrate in a peptidolytic assay to quantify the inhibition of the protease[1][2].

Name	2-[(2-acetamido-3-hydroxypropanoyl)amino]-N-[4-amino-1-[[1-[2-[[1-[(1-amino-3-methyl-1-oxobutan-2-yl)amino]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]pentanediamide
Synonym	More Synonyms

Description	Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 is a substrato peptídico of HIV-1 protease.Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 acts as the variable substrate in a peptidolytic assay to quantify the inhibition of the protease[1][2].
Related Catalog	Research Areas >> Others Signaling Pathways >> Metabolic Enzyme/Protease >> HIV Protease
References	[1]. Ana C. R. Sodero, et al. Mecanismo Catalítico e Estado de Protonação do Sítio Ativo de Aspartil Proteases Pepsina-Símiles.Revista Virtual de Química, v. 1 n. 2 (2009). [2]. G B Dreyer, et al. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9752-6.

Description

Related Catalog

Research Areas >> Others

Signaling Pathways >> Metabolic Enzyme/Protease >> HIV Protease

References

[1]. Ana C. R. Sodero, et al. Mecanismo Catalítico e Estado de Protonação do Sítio Ativo de Aspartil Proteases Pepsina-Símiles.Revista Virtual de Química, v. 1 n. 2 (2009).

[2]. G B Dreyer, et al. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9752-6.